% alzhub.org library filter
% Source: https://alzhub.org/research?author=Ferrer+I&access=free
% 7 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{barrachina2009-19606065,
  author  = {Barrachina, M. and Ferrer, I.},
  title   = {{DNA methylation of Alzheimer disease and tauopathy-related genes in postmortem brain}},
  journal = {Journal of neuropathology and experimental neurology},
  year    = {2009},
  doi     = {10.1097/nen.0b013e3181af2e46},
  pmid    = {19606065},
  url     = {https://doi.org/10.1097/nen.0b013e3181af2e46}
}

@article{aso2013-23515018,
  author  = {Aso, E. and Juvés, S. and Maldonado, R. and Ferrer, I.},
  title   = {{CB2 cannabinoid receptor agonist ameliorates Alzheimer-like phenotype in AβPP/PS1 mice}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2013},
  doi     = {10.3233/jad-130137},
  pmid    = {23515018},
  url     = {https://doi.org/10.3233/jad-130137}
}

@article{aso2014-24634659,
  author  = {Aso, E. and Ferrer, I.},
  title   = {{Cannabinoids for treatment of Alzheimer's disease: moving toward the clinic}},
  journal = {Frontiers in pharmacology},
  year    = {2014},
  doi     = {10.3389/fphar.2014.00037},
  pmid    = {24634659},
  url     = {https://doi.org/10.3389/fphar.2014.00037}
}

@article{garciaesparcia2018-29755340,
  author  = {Garcia-Esparcia, P. and Diaz-Lucena, D. and Ainciburu, M. and Torrejón-Escribano, B. and Carmona, M. and Llorens, F. and Ferrer, I.},
  title   = {{Glutamate Transporter GLT1 Expression in Alzheimer Disease and Dementia With Lewy Bodies}},
  journal = {Frontiers in aging neuroscience},
  year    = {2018},
  doi     = {10.3389/fnagi.2018.00122},
  pmid    = {29755340},
  url     = {https://doi.org/10.3389/fnagi.2018.00122}
}

@article{ferrer2005-16242644,
  author  = {Ferrer, I. and Barrachina, M. and Puig, B. and Martínez de Lagrán, M. and Martí, E. and Avila, J. and Dierssen, M.},
  title   = {{Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models}},
  journal = {Neurobiology of disease},
  year    = {2005},
  doi     = {10.1016/j.nbd.2005.03.020},
  pmid    = {16242644},
  url     = {https://doi.org/10.1016/j.nbd.2005.03.020}
}

@article{blanch2016-26776077,
  author  = {Blanch, M. and Mosquera, J. L. and Ansoleaga, B. and Ferrer, I. and Barrachina, M.},
  title   = {{Altered Mitochondrial DNA Methylation Pattern in Alzheimer Disease-Related Pathology and in Parkinson Disease}},
  journal = {The American journal of pathology},
  year    = {2016},
  doi     = {10.1016/j.ajpath.2015.10.004},
  pmid    = {26776077},
  url     = {https://doi.org/10.1016/j.ajpath.2015.10.004}
}

@article{angulo2003-14655750,
  author  = {Angulo, E. and Casadó, V. and Mallol, J. and Canela, E. I. and Viñals, F. and Ferrer, I. and Lluis, C. and Franco, R.},
  title   = {{A1 adenosine receptors accumulate in neurodegenerative structures in Alzheimer disease and mediate both amyloid precursor protein processing and tau phosphorylation and translocation}},
  journal = {Brain pathology (Zurich, Switzerland)},
  year    = {2003},
  doi     = {10.1111/j.1750-3639.2003.tb00475.x},
  pmid    = {14655750},
  url     = {https://doi.org/10.1111/j.1750-3639.2003.tb00475.x}
}